Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

The combination treatment showed a higher response rate but no significant survival benefits.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

4-aminopyridine helps skin wounds heal faster and better.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

A cat's hair loss was linked to a severe pancreatic cancer.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Perhexiline can effectively target ovarian cancer cells left after treatment.

PRP injections did not significantly improve ovarian function in women with low ovarian reserve.

Chemotherapy and certain hair care practices can cause severe hair matting.

A girl with Pitt-Hopkins syndrome developed curly hair as a rare side effect from the epilepsy drug perampanel.

Compound 7p shows strong potential as an anticancer agent.

Platelet-rich plasma may help heal injuries.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

New molecules can prevent cell death in hair follicles.

Nilotinib can cause generalized keratosis pilaris.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

A rare case linked complete hair loss to both pancreas and gallbladder cancer.

The NIPAL4 mutation c.527C>A is common in Romanian patients with autosomal recessive congenital ichthyosis.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.